Gene delivery strategies targeting stable atheromatous plaque.
Conventional therapeutic options to treat chronic angina pectoris are pharmacological interventions, coronary bypass surgery (CABG) and percutaneous coronary intervention (PCI). In animal models, it was shown that gene delivery strategies harbour an exciting potential to support and maybe even repla...
Главные авторы: | Van-Assche, T, Huygelen, V, Crabtree, M, Antoniades, C |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2013
|
Схожие документы
-
Gene therapy targeting inflammation in atherosclerosis.
по: Van-Assche, T, и др.
Опубликовано: (2011) -
Targeting vascular redox biology through antioxidant gene delivery: a historical view and current perspectives.
по: Van Assche, T, и др.
Опубликовано: (2011) -
Periodontal pathogens in atheromatous plaque
по: Saroj K. Rath, и др.
Опубликовано: (2014-01-01) -
Macrophages in Atheromatous Plaque Developmental Stages
по: Alexander von Ehr, и др.
Опубликовано: (2022-04-01) -
Letter to the Editor. Atheromatous Plaque Vulnerability — the Neglected Vulnerable Carotid Plaques
по: Péter Levente
Опубликовано: (2017-09-01)